Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume 38, Issue 5, Pages 2130-2158
Publisher
Springer Science and Business Media LLC
Online
2021-04-08
DOI
10.1007/s12325-021-01690-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term testosterone therapy improves liver parameters and steatosis in hypogonadal men: a prospective controlled registry study
- (2021) Aksam A. Yassin et al. Aging Male
- Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value
- (2021) Fátima Higuera-de-la-Tijera et al. DIGESTIVE DISEASES AND SCIENCES
- Non-alcoholic Fatty Liver and Liver Fibrosis Predictive Analytics: Risk Prediction and Machine Learning Techniques for Improved Preventive Medicine
- (2021) Orit Goldman et al. JOURNAL OF MEDICAL SYSTEMS
- Pathophysiology of NASH in endocrine diseases
- (2021) Karim Gariani et al. Endocrine Connections
- Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
- (2021) Alessandro Mantovani et al. Metabolites
- Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease
- (2021) Stefano Ballestri et al. Diagnostics
- The need for precision nutrition, genetic variation and resolution in Covid-19 patients
- (2021) Artemis P. Simopoulos et al. MOLECULAR ASPECTS OF MEDICINE
- Comparison of the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Metabolic Associated Fatty Liver Disease: Updated Systematic Review and Meta-Analysis
- (2021) Yuzhao Dai et al. Frontiers in Endocrinology
- Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?
- (2021) Amedeo Lonardo Journal of Clinical Medicine
- Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
- (2020) Stefano Romeo et al. Cell Metabolism
- GENETICS AND EPIGENETICS IN THE CLINIC: PRECISION MEDICINE IN THE MANAGEMENT OF FATTY LIVER DISEASE
- (2020) Annalisa Cespiati et al. CURRENT PHARMACEUTICAL DESIGN
- Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials
- (2020) A. Mantovani et al. DIABETES & METABOLISM
- The ‘Digital Twin’ to enable the vision of precision cardiology
- (2020) Jorge Corral-Acero et al. EUROPEAN HEART JOURNAL
- Towards genetic prediction of non-alcoholic fatty liver disease trajectories: PNPLA3 and beyond
- (2020) Marcin Krawczyk et al. GASTROENTEROLOGY
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- NAFLD 2020: The State of the Disease
- (2020) Thomas G. Cotter et al. GASTROENTEROLOGY
- Advances in non-invasive assessment of hepatic fibrosis
- (2020) Rohit Loomba et al. GUT
- Thyroid hormones and thyromimetics: A new approach to NASH?
- (2020) Rohit Anthony Sinha et al. HEPATOLOGY
- Treatment of hepatocellular carcinoma in the Precision Medicine era: from treatment stage migration to therapeutic hierarchy
- (2020) Alessandro Vitale et al. HEPATOLOGY
- “Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era
- (2020) Donato Gemmati et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gut microbiome in HCC – Mechanisms, diagnosis and therapy
- (2020) Robert F. Schwabe et al. JOURNAL OF HEPATOLOGY
- Update on NAFLD genetics: from new variants to the clinic
- (2020) Eric Trépo et al. JOURNAL OF HEPATOLOGY
- Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
- (2020) Javier Ampuero et al. JOURNAL OF HEPATOLOGY
- Complications, morbidity and mortality of nonalcoholic fatty liver disease
- (2020) Alessandro Mantovani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of SGLT2 Inhibitors on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Meta‐Analysis of Randomized Controlled Trials
- (2020) Baodi Xing et al. Journal of Diabetes Investigation
- Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review
- (2020) Stefano Ballestri et al. ADVANCES IN THERAPY
- Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis
- (2020) Björn Carlsson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Non-alcoholic Steatohepatitis-related, Child-Pugh A Cirrhosis
- (2020) Eduardo Vilar-Gomez et al. Clinical Gastroenterology and Hepatology
- Women have Lower Risk of Nonalcoholic Fatty Liver Disease but Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis
- (2020) Maya Balakrishnan et al. Clinical Gastroenterology and Hepatology
- Accuracy of 2-dimensional Shear Wave Elastography and Attenuation Imaging for Evaluation of Patients With Nonalcoholic Steatohepatitis
- (2020) Dong Ho Lee et al. Clinical Gastroenterology and Hepatology
- Why do so many NASH trials fail?
- (2020) Vlad Ratziu et al. GASTROENTEROLOGY
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- Genetic pathways in nonalcoholic fatty liver disease: Insights from systems biology
- (2020) Silvia Sookoian et al. HEPATOLOGY
- Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis
- (2020) Yasaman Vali et al. JOURNAL OF HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’
- (2020) Yasser Fouad et al. LIVER INTERNATIONAL
- Physical activity is associated with lower health care costs among Taiwanese individuals with diabetes mellitus
- (2020) Chun-Lang Su et al. MEDICINE
- Effects of high-intensity interval and moderate-intensity continuous aerobic exercise on diabetic obese patients with nonalcoholic fatty liver disease
- (2020) Walid Kamal Abdelbasset et al. MEDICINE
- Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research
- (2020) Amedeo Lonardo et al. Journal of Clinical Medicine
- Microbiota and Fatty Liver Disease—the Known, the Unknown, and the Future
- (2020) Sonja Lang et al. Cell Host & Microbe
- A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
- (2020) Tae Gyu Oh et al. Cell Metabolism
- Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2020) Wendy K. Chung et al. DIABETOLOGIA
- NAFLD and NASH in postmenopausal women: implications for diagnosis and treatment
- (2020) Johanna K DiStefano ENDOCRINOLOGY
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- MAFLD vs NAFLD: Let the contest begin!
- (2020) Cristiana Bianco et al. LIVER INTERNATIONAL
- The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
- (2020) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future
- (2020) Leon A. Adams et al. SEMINARS IN LIVER DISEASE
- NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
- (2020) Amélio F. Godoy-Matos et al. Diabetology & Metabolic Syndrome
- Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men
- (2020) E. Maseroli et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Metabolic Footprint, towards Understanding Type 2 Diabetes beyond Glycemia
- (2020) Ana F. Pina et al. Journal of Clinical Medicine
- Non-alcoholic fatty liver disease (NAFLD) diagnosis and management—differentiating the essential from the ancillary and the present from the future
- (2020) Amedeo Lonardo et al. Hepatobiliary Surgery and Nutrition
- A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
- (2020) Stephen A Harrison et al. Lancet Gastroenterology & Hepatology
- Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population
- (2020) Rommel Zambrano-Huailla et al. Annals of Hepatology
- Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
- (2020) Juan Pablo Arab et al. Annals of Hepatology
- Physiological sex differences affect the integrative response to exercise: Acute and chronic implications
- (2020) Paul Ansdell et al. EXPERIMENTAL PHYSIOLOGY
- The nonalcoholic steatohepatitis (NASH) drug development graveyard: established hurdles and planning for future success
- (2020) Joost P.H. Drenth et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
- (2020) Alessandro Mantovani et al. GUT
- The application of artificial intelligence for the diagnosis and treatment of liver diseases
- (2020) Joseph C Ahn et al. HEPATOLOGY
- Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options
- (2020) Daniela Maria Tanase et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- History of Nonalcoholic Fatty Liver Disease
- (2020) Amedeo Lonardo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The PNPLA3-I148M variant confers an antiatherogenic lipid profile in insulin-resistant patients
- (2020) Panu K Luukkonen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The times they are a-changin' (for NAFLD as well)
- (2020) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- FIB-4 cut-off should be re-evaluated in patients with metabolic associated fatty liver disease (MAFLD)
- (2020) Yinlian Wu et al. JOURNAL OF HEPATOLOGY
- Sex and gender: modifiers of health, disease, and medicine
- (2020) Franck Mauvais-Jarvis et al. LANCET
- Prognostic accuracy of FIB‐4, NAFLD fibrosis score, and APRI for NAFLD‐related events: a systematic review
- (2020) Jenny Lee et al. LIVER INTERNATIONAL
- Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD
- (2020) Giljae Lee et al. Nature Communications
- Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling
- (2020) Sara Della Torre Frontiers in Endocrinology
- Redefining fatty liver disease: an international patient perspective
- (2020) Gamal Shiha et al. Lancet Gastroenterology & Hepatology
- Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
- (2020) Silvia Sookoian et al. Clinical and Molecular Hepatology
- Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease
- (2020) S.R. Sharpton et al. Cell Metabolism
- Macronutrients, microbiome and precision nutrition
- (2020) John O’Grady et al. CURRENT OPINION IN GASTROENTEROLOGY
- NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
- (2020) Giovanni Targher et al. DIABETES & METABOLISM
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- 3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review
- (2020) Zobair M. Younossi et al. GASTROENTEROLOGY
- Precision medicine in the era of artificial intelligence: implications in chronic disease management
- (2020) Murugan Subramanian et al. Journal of Translational Medicine
- Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
- (2020) Daniel Q. Huang et al. Nature Reviews Gastroenterology & Hepatology
- The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease
- (2020) Nahum Mendez-Sanchez et al. Lancet Gastroenterology & Hepatology
- Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa
- (2020) Gamal Shiha et al. Lancet Gastroenterology & Hepatology
- Lipid-lowering therapy: Guidelines to precision medicine
- (2020) Xin Su et al. CLINICA CHIMICA ACTA
- Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
- (2020) Cristiana Bianco et al. JOURNAL OF HEPATOLOGY
- Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?
- (2019) Amedeo Lonardo et al. DIGESTIVE AND LIVER DISEASE
- Sex Differences in NAFLD : State of the Art and Identification of Research Gaps
- (2019) Amedeo Lonardo et al. HEPATOLOGY
- Precision exercise medicine: understanding exercise response variability
- (2019) Robert Ross et al. BRITISH JOURNAL OF SPORTS MEDICINE
- Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
- (2019) Raul D. Santos et al. ATHEROSCLEROSIS
- Gut microbiome–targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression
- (2019) Suzanne R Sharpton et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes
- (2019) Fabio Nascimbeni et al. ATHEROSCLEROSIS
- Past, present and future perspectives in nonalcoholic fatty liver disease
- (2019) Arun J. Sanyal Nature Reviews Gastroenterology & Hepatology
- Dyslipidemia in nonalcoholic fatty liver disease
- (2019) Antonio J. Amor et al. Current Opinion in Endocrinology Diabetes and Obesity
- Editorial: Precision Physical Activity and Exercise Prescriptions for Disease Prevention: The Effect of Interindividual Variability Under Different Training Approaches
- (2019) Robinson Ramírez-Vélez et al. Frontiers in Physiology
- Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
- (2019) Daniel Lindén et al. Molecular Metabolism
- Nonalcoholic fatty liver disease: does sex matter?
- (2019) Amedeo Lonardo et al. HEPATOBILIARY SURGERY AND NUTRITION
- Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
- (2019) Javier Ampuero et al. Clinical Gastroenterology and Hepatology
- NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management
- (2019) Amedeo Lonardo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sex matters: a focus on the impact of biological sex on metabolomic profiles and dietary interventions
- (2019) Lorraine Brennan et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- Concurrent nonalcoholic liver disease and type 2 diabetes: diagnostic and therapeutic considerations
- (2019) Marco Arrese et al. Expert Review of Gastroenterology & Hepatology
- Primer on Precision Medicine for Complex Chronic Disorders
- (2019) David C. Whitcomb Clinical and Translational Gastroenterology
- Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease
- (2019) Stefano Ballestri et al. Future Medicinal Chemistry
- The Risk of Incident Extrahepatic Cancers is higher in Nonalcoholic Fatty Liver Disease than Obesity - a Longitudinal Cohort Study
- (2019) Alina M. Allen et al. JOURNAL OF HEPATOLOGY
- Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2019) Stephen A Harrison et al. LANCET
- Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis
- (2019) Monika Sarkar et al. LIVER INTERNATIONAL
- Gut microbiota in non‐alcoholic fatty liver disease and alcohol‐related liver disease: Current concepts and perspectives
- (2019) Juan P. Arab et al. HEPATOLOGY RESEARCH
- Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease
- (2019) Ze Chen et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered
- (2019) Maria Corina Plaz Torres et al. Nutrients
- Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
- (2018) Juan Pablo Arab et al. Annual Review of Pathology-Mechanisms of Disease
- Emerging Role of Precision Medicine in Cardiovascular Disease
- (2018) Jane A. Leopold et al. CIRCULATION RESEARCH
- Vibration-controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Mohammad S. Siddiqui et al. Clinical Gastroenterology and Hepatology
- The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View
- (2018) Christina C. Lindenmeyer et al. Clinics in Liver Disease
- Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives
- (2018) Vasiliki Venetsanaki et al. Current Vascular Pharmacology
- Nonalcoholic fatty liver disease and hypertension
- (2018) Dimitrios Oikonomou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease
- (2018) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
- (2018) Eduardo Vilar-Gomez et al. JOURNAL OF HEPATOLOGY
- Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
- (2018) Thomas Jensen et al. JOURNAL OF HEPATOLOGY
- Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
- (2018) Héctor F. Escobar-Morreale Nature Reviews Endocrinology
- Triggering and resolution of inflammation in NASH
- (2018) Susanne Schuster et al. Nature Reviews Gastroenterology & Hepatology
- Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
- (2018) Carlos J Pirola et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Men and women respond differently to rapid weight loss: Metabolic outcomes of a multi-centre intervention study after a low-energy diet in 2500 overweight, individuals with pre-diabetes (PREVIEW)
- (2018) Pia Christensen et al. DIABETES OBESITY & METABOLISM
- Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease
- (2018) Huikuan Chu et al. GUT
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- Omics, big data and machine learning as tools to propel understanding of biological mechanisms and to discover novel diagnostics and therapeutics
- (2018) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
- (2018) Alessandro Mantovani et al. THYROID
- A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?
- (2018) Amedeo Lonardo et al. ACTA DIABETOLOGICA
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver
- (2017) Yutaka Takahashi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
- (2017) Ryuki Hashida et al. JOURNAL OF HEPATOLOGY
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- The epidemiology of non-alcoholic fatty liver disease
- (2017) Stefano Bellentani LIVER INTERNATIONAL
- Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis
- (2017) Christina N Katsagoni et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Caloric restriction improves health and survival of rhesus monkeys
- (2017) Julie A. Mattison et al. Nature Communications
- Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota
- (2016) Sena Bluemel et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD)
- (2016) Salamah Mohammad Alwahsh et al. ARCHIVES OF TOXICOLOGY
- Stable Engraftment of Bifidobacterium longum AH1206 in the Human Gut Depends on Individualized Features of the Resident Microbiome
- (2016) María X. Maldonado-Gómez et al. Cell Host & Microbe
- Sex Differences in Lifespan
- (2016) Steven N. Austad et al. Cell Metabolism
- A “systems medicine” approach to the study of non-alcoholic fatty liver disease
- (2016) Salvatore Petta et al. DIGESTIVE AND LIVER DISEASE
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Gut Microbiota and Lifestyle Interventions in NAFLD
- (2016) David Houghton et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas
- (2016) Matthias K. Auer et al. Pituitary
- PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery
- (2016) Marcin Krawczyk et al. Surgery for Obesity and Related Diseases
- The Role of Cholesterol in the Pathogenesis of NASH
- (2016) George N. Ioannou TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease
- (2016) Hui-Jie Zhang et al. JAMA Internal Medicine
- Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
- (2015) Graciela Arguello et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile
- (2015) Mohammad S. Siddiqui et al. Clinical Gastroenterology and Hepatology
- Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice
- (2015) Jose Cordoba-Chacon et al. DIABETES
- Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis
- (2015) Siddharth Singh et al. EUROPEAN RADIOLOGY
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial
- (2015) Leon A. Adams et al. HEPATOLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Heterogeneity of non-alcoholic fatty liver disease
- (2015) Hannele Yki-Järvinen et al. LIVER INTERNATIONAL
- Nonalcoholic steatohepatitis in precision medicine: Unraveling the factors that contribute to individual variability
- (2015) John D. Clarke et al. PHARMACOLOGY & THERAPEUTICS
- Exercise is medicine: a call to action for physicians to assess and prescribe exercise
- (2015) Robert Sallis PHYSICIAN AND SPORTSMEDICINE
- Acoustic Radiation Force Impulse Elastography for the Non-Invasive Evaluation of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review & Meta-Analysis
- (2015) Haixia Liu et al. PLoS One
- PNPLA3gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease
- (2014) Jiayun Shen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Abnormalities in the Growth Hormone Axis and Risk of Nonalcoholic Steatohepatitis: Active Player or Innocent Bystander?
- (2014) Stavra A. Xanthakos et al. JOURNAL OF PEDIATRICS
- A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease
- (2014) Umut Emre Aykut et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial
- (2014) Shira Zelber-Sagi WORLD JOURNAL OF GASTROENTEROLOGY
- Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis
- (2013) Ju Dong Yang et al. HEPATOLOGY
- P4 medicine: how systems medicine will transform the healthcare sector and society
- (2013) Mauricio Flores et al. Personalized Medicine
- Pathogenesis of hepatic steatosis: The link between hypercortisolism and non-alcoholic fatty liver disease
- (2013) Giovanni Tarantino WORLD JOURNAL OF GASTROENTEROLOGY
- Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study
- (2012) L. Gerber et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Potential for statins in the chemoprevention and management of hepatocellular carcinoma
- (2012) Amedeo Lonardo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population
- (2012) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Predictive, personalized, preventive, participatory (P4) cancer medicine
- (2011) Leroy Hood et al. Nature Reviews Clinical Oncology
- Overweight and hypertriglyceridemia are risk factors for liver cirrhosis in middle-aged Swedish men
- (2011) Andreas Schult et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis
- (2010) Zhong-Hua Lin et al. HEPATOLOGY
- Dominant and diet-responsive groups of bacteria within the human colonic microbiota
- (2010) Alan W Walker et al. ISME Journal
- Endocrine and liver interaction: the role of endocrine pathways in NASH
- (2009) Paola Loria et al. Nature Reviews Gastroenterology & Hepatology
- Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Utility of FIBROspect II to Detect Liver Fibrosis in Morbidly Obese Hispano-American Patients Undergoing Gastric Bypass
- (2009) Gustavo Eugenio Guajardo-Salinas et al. OBESITY SURGERY
- Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels
- (2008) F. Morisco et al. DIGESTIVE AND LIVER DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search